FDA approves clinical bone sonometer

17 Jun 2002

The U.S. Food and Drug Administration has approved the SAHARA clinincal bone sonometer produced by Hologic, Inc., which can be used to aid physicians in the diagnosis of osteoporosis. The bone densitometer is the first in the U.S. that does not use ionizing radiation (X-ray) and thus does not require a licensed operator. The SAHARA densitometer assesses a patient's skeletal status by measuring bone mineral density at the heel. With the FDA approval, SAHARA will be marketed by Physician Sales and Service, Inc.